Immediate Impact
4 from Science/Nature 12 standout
Citing Papers
Medical Image Segmentation Review: The Success of U-Net
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Shuo Ma being referenced
Robust Human Motion Forecasting using Transformer-based Model
2022
A Phase 1/2 Study of Umbralisib, Ublituximab, and Venetoclax (U2-Ven) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Shuo Ma | 45 | 43 | 30 | 86 | 80 | 38 | 271 | |
| Viorel‐Puiu Paun | 16 | 25 | 23 | 51 | 10 | 47 | 299 | |
| Chiranjib Sur | 10 | 11 | 25 | 164 | 41 | 32 | 292 | |
| William R. Davis | 8 | 65 | 18 | 57 | 10 | 24 | 319 | |
| Werner Benger | 56 | 5 | 21 | 22 | 25 | 30 | 259 | |
| David Nicholson | 50 | 20 | 16 | 66 | 24 | 29 | 253 | |
| R. Stollé | 5 | 62 | 22 | 129 | 71 | 32 | 276 | |
| Alexander Meier | 7 | 43 | 42 | 46 | 15 | 20 | 267 | |
| Montasir Qasymeh | 7 | 175 | 27 | 171 | 87 | 39 | 330 | |
| Shinnosuke Hattori | 33 | 173 | 74 | 109 | 8 | 30 | 303 | |
| Xuyang Chen | 17 | 88 | 41 | 31 | 9 | 29 | 282 |
All Works
Loading papers...